Table 2 Comparisons of log-transformed leptin and log-transformed A-FABP levels in adult onset MS patients to healthy controls
From: Increased leptin and A-FABP levels in relapsing and progressive forms of MS
Adjusted for batch and age | Adjusted for batch, age and BMI | ||
|---|---|---|---|
Leptin | Healthy controls | Reference | Reference |
Relapsing remitting MS | 0.66 +/− 0.28 (0.020) | 0.43 +/− 0.23 (0.067) | |
Secondary progressive MS | 1.01 +/− 0.33 (0.003) | 0.59 +/− 0.28 (0.041) | |
Primary progressive MS | 0.16 +/− 0.34 (0.63) | −0.09 +/− 0.28 (0.74) | |
Four group comparison p-value | 0.008 | 0.054 | |
A-FABP | Healthy controls | Reference | Reference |
Relapsing remitting MS | 0.07 +/− 0.17 (0.69) | 0.02 +/− 0.17 (0.90) | |
Secondary progressive MS | 0.49 +/− 0.21 (0.021) | 0.34 +/− 0.21 (0.098) | |
Primary progressive MS | 0.26 +/− 0.18 (0.16) | 0.15 +/− 0.18 (0.41) | |
Four group comparison p-value | 0.117 | 0.403 |